510(k) K770459
K770459 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "URIC ACID PROCEDURE, TEKPOINT DIRECT". The FDA issued a decision of Substantially Equivalent on April 29, 1977. The device falls under product code CDH (Acid, Uric, Phosphotungstate Reduction), a Class I device regulated under 21 CFR 862.1775. Icn Pharmaceuticals, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 29, 1977
- Date Received
- March 8, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Acid, Uric, Phosphotungstate Reduction
- Device Class
- Class I
- Regulation Number
- 862.1775
- Review Panel
- CH
- Submission Type